<DOC>
	<DOC>NCT01886690</DOC>
	<brief_summary>This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.</brief_summary>
	<brief_title>A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Patients scheduled for LASIK surgery in both eyes. Any systemic medication use within 3 months of screening (including over the counter, herbal, prescription, or nutritional supplement) which may affect dry eye or vision Use of topical eye medication other than prescribed for use in pre or postoperative care Use of RESTASIS® or other topical ophthalmic cyclosporine product within 6 months prior to Screening Eye infection, inflammation, or allergy Soft contact lenses in the previous 7 days or rigid contact lenses in the previous 30 days prior to LASIK surgery.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>